Bhaskar Anand insider trades

Open-market stock purchases and sales by Bhaskar Anand, Chief Accounting Officer at Summit Therapeutics Inc, from SEC Form 4 filings since Jan 3, 2022.

Recent trades

DateStockTradeValue
Jan 8, 2026SMMT Summit Therapeutics IncBought (not open market)$565K
Oct 21, 2025SMMT Summit Therapeutics IncBought (not open market)$500K

Companies traded

  • SMMT Summit Therapeutics Inc: other filings, last Jan 8, 2026
  • RETA Reata Pharmaceuticals Inc: 8 sales, last Sep 26, 2023

Get free alerts when Bhaskar Anand files a new trade →